IDEXX Laboratories EVP Johnny Powers Unloads 13,128 Shares (IDXX)
IDEXX Laboratories (NASDAQ:IDXX) EVP Johnny Powers sold 13,128 shares of IDEXX Laboratories stock on the open market in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $96.59, for a total value of $1,268,033.52. Following the sale, the executive vice president now directly owns 8,989 shares in the company. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Separately, analysts at Stifel Nicolaus upgraded shares of IDEXX Laboratories (NASDAQ:IDXX) from a “hold” rating to a “buy” rating in a research note to investors on Monday, July 15th. They now have a $110.00 price target on the stock.
Shares of IDEXX Laboratories (NASDAQ:IDXX) traded up 1.06% on Tuesday, hitting $98.07. The stock had a trading volume of 139,874 shares. IDEXX Laboratories has a 52-week low of $81.57 and a 52-week high of $101.18. The stock has a 50-day moving average of $96.60 and a 200-day moving average of $91.33. The company has a market cap of $5.153 billion and a price-to-earnings ratio of 29.08.
IDEXX Laboratories (NASDAQ:IDXX) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. The company had revenue of $352.60 million for the quarter, compared to the consensus estimate of $356.80 million. During the same quarter in the previous year, the company posted $0.91 earnings per share. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. Analysts expect that IDEXX Laboratories will post $3.46 EPS for the current fiscal year.
IDEXX Laboratories, Inc develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.